Literature DB >> 16437580

Sarcolemmal reorganization in facioscapulohumeral muscular dystrophy.

Patrick Reed1, Neil C Porter, John Strong, David W Pumplin, Andrea M Corse, Paul W Luther, Kevin M Flanigan, Robert J Bloch.   

Abstract

OBJECTIVE: We examined the sarcolemma of skeletal muscle from patients with facioscapulohumeral muscular dystrophy (FSHD1A) to learn if, as in other murine and human muscular dystrophies, its organization and relationship to nearby contractile structures are altered.
METHODS: Unfixed biopsies of control and FSHD deltoid and biceps muscles, snap-frozen at resting length, were cryosectioned, indirectly immunolabeled with fluorescent antibodies to sarcolemmal and myofibrillar markers, and examined with confocal microscopy to localize the immunolabeled proteins. Glutaraldehyde-fixed samples were stained with heavy metals, embedded, thin-sectioned, and examined with electron microscopy to determine the relationship between the sarcolemma and the underlying myofibrils.
RESULTS: Confocal microscopy showed that some of the structures at the sarcolemma in FSHD samples were misaligned with respect to the underlying contractile apparatus. Electron microscopy showed a significant increase in the distance between the sarcolemma and the nearest myofibrils, from less than 100 nm in controls to values as high as 550 nm in FSHD.
INTERPRETATION: Our results show that the pathophysiology of FSHD includes novel changes in the organization of the sarcolemma and its association with nearby contractile structures and suggest that, as in other muscular dystrophies, the integrity of the sarcolemma may be compromised in FSHD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16437580     DOI: 10.1002/ana.20750

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  15 in total

1.  Facioscapulohumeral muscular dystrophy region gene-1 (FRG-1) is an actin-bundling protein associated with muscle-attachment sites.

Authors:  Qian Liu; Takako Iida Jones; Vivian W Tang; William M Brieher; Peter L Jones
Journal:  J Cell Sci       Date:  2010-03-09       Impact factor: 5.285

2.  Unmasking potential intracellular roles for dysferlin through improved immunolabeling methods.

Authors:  Joseph A Roche; Lisa W Ru; Andrea M O'Neill; Wendy G Resneck; Richard M Lovering; Robert J Bloch
Journal:  J Histochem Cytochem       Date:  2011-11       Impact factor: 2.479

Review 3.  Deciphering transcription dysregulation in FSH muscular dystrophy.

Authors:  Melanie Ehrlich; Michelle Lacey
Journal:  J Hum Genet       Date:  2012-06-21       Impact factor: 3.172

4.  Facioscapulohumeral dystrophy: case report and discussion.

Authors:  Vincenzo Castellano; Joseph Feinberg; Jennifer Michaels
Journal:  HSS J       Date:  2008-07-01

5.  Sarcomeric dysfunction contributes to muscle weakness in facioscapulohumeral muscular dystrophy.

Authors:  Saskia Lassche; Ger J M Stienen; Tom C Irving; Silvère M van der Maarel; Nicol C Voermans; George W Padberg; Henk Granzier; Baziel G M van Engelen; Coen A C Ottenheijm
Journal:  Neurology       Date:  2013-01-30       Impact factor: 9.910

6.  Transcriptional regulation differs in affected facioscapulohumeral muscular dystrophy patients compared to asymptomatic related carriers.

Authors:  Patricia Arashiro; Iris Eisenberg; Alvin T Kho; Antonia M P Cerqueira; Marta Canovas; Helga C A Silva; Rita C M Pavanello; Sergio Verjovski-Almeida; Louis M Kunkel; Mayana Zatz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-01       Impact factor: 11.205

7.  Deregulation of the protocadherin gene FAT1 alters muscle shapes: implications for the pathogenesis of facioscapulohumeral dystrophy.

Authors:  Nathalie Caruso; Balàzs Herberth; Marc Bartoli; Francesca Puppo; Julie Dumonceaux; Angela Zimmermann; Simon Denadai; Marie Lebossé; Stephane Roche; Linda Geng; Frederique Magdinier; Shahram Attarian; Rafaelle Bernard; Flavio Maina; Nicolas Levy; Françoise Helmbacher
Journal:  PLoS Genet       Date:  2013-06-13       Impact factor: 5.917

8.  Facioscapulohumeral muscular dystrophy (FSHD) region gene 1 (FRG1) is a dynamic nuclear and sarcomeric protein.

Authors:  Meredith L Hanel; Chia-Yun Jessica Sun; Takako I Jones; Steven W Long; Simona Zanotti; Derek Milner; Peter L Jones
Journal:  Differentiation       Date:  2011-02       Impact factor: 3.880

9.  AAV6-mediated systemic shRNA delivery reverses disease in a mouse model of facioscapulohumeral muscular dystrophy.

Authors:  Sergia Bortolanza; Alessandro Nonis; Francesca Sanvito; Simona Maciotta; Giovanni Sitia; Jessica Wei; Yvan Torrente; Clelia Di Serio; Joel R Chamberlain; Davide Gabellini
Journal:  Mol Ther       Date:  2011-08-09       Impact factor: 11.454

10.  Absence of keratin 19 in mice causes skeletal myopathy with mitochondrial and sarcolemmal reorganization.

Authors:  Michele R Stone; Andrea O'Neill; Richard M Lovering; John Strong; Wendy G Resneck; Patrick W Reed; Diana M Toivola; Jeanine A Ursitti; M Bishr Omary; Robert J Bloch
Journal:  J Cell Sci       Date:  2007-10-30       Impact factor: 5.235

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.